In Vitro Diagnostics Business Outlook: Volume 1, Issue 6 - Coagulation Testing
A new twice-monthly publication dedicated to IVD, In Vitro Diagnostics Business Outlook offers the following:
• Market Sizing and Forecasting of IVD Market Segments in Every Issue
• Clinical Chemistry, Infectious Disease Testing, Oncology, Hematology, Blood Banking, Coagulation, Point of Care–Updates on the Important Test Categories You Need to Know About
• Industry Watch – Developments with COVID-19 and Other Testing
• M&A, Distribution, Partnerships Tracked and Charted
• New Product Introductions and Company Announcements
• Company Profiling and Quarterly Results Summaries
• Regional Market Coverage
-
Market Analysis: Focus on Coagulation Testing
-
Overview of Diagnostics in Coagulation
-
Market Outlook
-
Major Product Activity
-
Laboratory vs. Point-of-Care Markets
-
Regional Market
-
Top Company Briefs
-
Executive News Briefing
-
Bio-Techne Appoints New President of Protein Sciences Segment
-
Mainz BioMed Appoints New VP of Regulatory Affairs
-
Lifespin GmbH Secures Financing
-
Numares Appoints New Member to Supervisory Board
-
Predicine Appoints New CFO
-
Financial Highlights: Agilent, Myriad Genetics and OraSure Technologies
-
Agilent Reports ‘Record-Setting Performance’ in Fiscal 2021
-
Myriad Genetics Reports 15% Growth in Third Quarter 2021
-
OraSure Technologies Focuses on InteliSwab Growth for FY22
-
Diagnostic Market Mergers, Acquisitions and Partnership Deals
-
Mergers and Acquisitions
-
Partnerships and Collaborations
-
Industry Watch
-
Region Watch
-
Broad-based Company Announcements
-
pdf - IVDBO - Vol 1. Issue 6.pdf